TriSalus Life Sciences, Inc. Increase (Decrease) in Due to Officers and Stockholders
TriSalus Life Sciences, Inc. (TLSI) reported Increase (Decrease) in Due to Officers and Stockholders of -$48.13 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-02.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueToOfficersAndStockholders · last filed 2023-08-02
- TriSalus Life Sciences, Inc. increase (decrease) in due to officers and stockholders for the quarter ending 2023-06-30 was $0.00.
- TriSalus Life Sciences, Inc. increase (decrease) in due to officers and stockholders for the quarter ending 2023-03-31 was -$48.13K.
| Period end | Increase (Decrease) in Due to Officers and Stockholders 3 month | Increase (Decrease) in Due to Officers and Stockholders 6 month |
|---|---|---|
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | -$48.13K 10-Q · filed 2023-08-02 |
| 2023-03-31 | -$48.13K 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |